Health ❯ Healthcare ❯ Vaccines

Covid-19 Vaccines

mRNA Vaccines Novavax Vaccine Pfizer Vaccine Safety and Efficacy Moderna Covid Vaccine Safety Novavax Covid Vaccine FDA Regulations FDA Recommendations Comirnaty

FDA Advisers Recommend XFG as Target for 2026–2027 COVID-19 Vaccines

The recommendation steers fall vaccine production toward XFG to boost protection against the currently dominant JN.1-family strains.

Cofepris Says Pfizer Has Not Filed Required Papers for Private Covid-19 Vaccine Sales in Mexico

France to Launch Coupled Flu and Covid Vaccination Campaign Tuesday for 19 Million

Mexico Clears Updated COVID-19 Vaccines Targeting LP.8.1 for 2025–26 Season

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Moderna’s Combined COVID-19 and Flu Vaccine Shows Promising Phase III Results

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Moderna Stock Surges After Bird Flu Vaccine Developments and Rising Respiratory Illness Rates

FDA Authorizes New Novavax Vaccine Targeting Omicron Variant

Moderna Lowers Annual Sales Forecast Amid Competitive Vaccine Market